Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population

Cancer

Volumn 116, Issue 20, 2010, Pages 4840-4848

  Fairfield, Kathleen M ^a   Lee Lucas, F ^a   Earle, Craig C ^b   Small, Laurie ^a   Trimble, Edward L ^c   Warren, Joan L ^c  

^a MAINE MEDICAL CENTER   (United States)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; Disparities; Epidemiology; Ovarian cancer; Regional variation

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CAUCASIAN; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MEDICARE; OVARY CARCINOMA; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; REGIONALIZATION; CANCER REGISTRY; MORTALITY; OVARY TUMOR; UNITED STATES;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MEDICARE; OVARIAN NEOPLASMS; SEER PROGRAM; UNITED STATES;

EID: 78349269095     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25242     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts and Figures 2008. Atlanta, Ga: American Cancer Society; 2008.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66. (Pubitemid 46148091)
3. Wakabayashi MT, Lin PS, Hakim AA. The role of cytoreductive/debulking surgery in ovarian cancer. J Natl Compr Canc Netw. 2008;6:803-810.
4. Munoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol. 1997;15:3408-3415. (Pubitemid 27485862)
5. Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol. 2003;21:3488-3494. (Pubitemid 46594082)
6. [No authors listed] Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA. 1995;273:491-497.
7. McGowan L. Patterns of care in carcinoma of the ovary. Cancer. 1993;71:628-633. (Pubitemid 23021261)
8. McGowan L, Lesher LP, Norris HJ, et al. Misstaging of ovarian cancer. Obstet Gynecol. 1985;65:568-572. (Pubitemid 15099160)
9. Nguyen HN, Averette HE, Hoskins W, et al. National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival. Cancer. 1993;72:3663-3670.
10. Eisenkop SM, Spirtos NM, Montag TW, et al. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol. 1992;47:203-209. (Pubitemid 23001329)
11. Earle CC, Schrag D, Neville BA, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006;98:172-180. (Pubitemid 43205479)
12. Wennberg J, Gittelsohn J. Small area variations in health care delivery. Science. 1973;182:1102-1108.
13. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med. 2003;138:273-287. (Pubitemid 36205924)
14. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003;138:288-298. (Pubitemid 36205925)
15. Ries LAG, Melbert D, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2005. Bethesda, Md: National Cancer Institute; 2008.
16. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer. 1995;76:2343-2350.
17. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the Surveillance, Epidemiology, and End Results Registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol. 1997;50:939-945. (Pubitemid 27423524)
18. Potosky AL, Riley GF, Lubitz JD, et al. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31:732-748.
19. Wennberg JE, Cooper MM, eds. The Dartmouth Atlas of Health Care. Chicago, Ill: American Hospital Association; 1996.
20. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002;40:IV-26-IV-35.
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
22. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
23. US Department of Health and Human Services. Area Resource File (ARF). In: Health Resources and Services Administration, Baby Oral Health Program, eds. Rockville, Md: Health Resources and Services Administration, US Department of Health and Human Services; 2006.
24. Polsky D, Armstrong KA, Randall TC, et al. Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography. Health Serv Res. 2007;41:2201-2218. (Pubitemid 44760150)